<p>摩特世（NYSE:WAT - 獲取免費報告）在週二發佈的研究報告中，分析師將其目標價格從 370.00 美元上調至 400.00 美元，彭博社報道。該券商目前對這家醫療儀器供應商的股票給予 “中性” 評級。摩特世的目標價格暗示該公司當前價格有 7.78% 的潛在上漲空間。</p>
<ul>
<li>安捷倫科技因 “永恆化學品” 打擊而蓬勃發展</li>
</ul>
<p>WAT 還受到其他多份研究報告的關注。摩根士丹利在 2 月 22 日的研究報告中將摩特世的目標價格從 423.00 美元下調至 350.00 美元，並給予該公司 “等權重” 評級。Weiss Ratings 在 4 月 20 日的研究報告中重申了對摩特世股票的 “持有（c）” 評級。富國銀行在 5 月 14 日的研究報告中將摩特世的目標價格從 355.00 美元上調至 370.00 美元，並給予該公司 “等權重” 評級。TD Cowen 在 5 月 6 日的研究報告中將摩特世的目標價格從 345.00 美元上調至 385.00 美元，並給予該股票 “持有” 評級。最後，古根海姆在 2 月 10 日的研究報告中重新發布了 “買入” 評級，並對摩特世股票設定了 440.00 美元的目標價格。三位分析師給予該股票 “強烈買入” 評級，九位給予 “買入” 評級，八位給予 “持有” 評級。根據 MarketBeat.com 的數據，摩特世目前的共識評級為 “適度買入”，平均目標價格為 395.71 美元。</p>
<p><strong>查看我們對摩特世的最新股票分析</strong></p>
<h2>摩特世股票表現</h2>
<ul>
<li>醫療股票摩特世、安捷倫、Illumina 顯示增長潛力</li>
</ul>
<p>週二中午交易時，WAT 的股價下跌 5.86 美元，跌至 371.11 美元。該股票的交易量為 1,529,432 股，而其平均交易量為 1,186,656 股。該公司的市值為 364.4 億美元，市盈率為 47.49，市盈增長比率為 2.42，貝塔值為 1.21。該公司的 50 日簡單移動平均線為 325.28 美元，200 日簡單移動平均線為 350.93 美元。該公司的速動比率為 1.13，流動比率為 1.79，債務與股本比率為 0.32。摩特世的 52 周低點為 275.05 美元，52 周高點為 414.15 美元。</p>
<p>摩特世（NYSE:WAT - 獲取免費報告）在 5 月 5 日最後發佈了其財報。這家醫療儀器供應商報告本季度每股收益為 2.70 美元，超出市場共識預期的 2.31 美元，超出幅度為 0.39 美元。該公司本季度的收入為 12.7 億美元，而分析師預期為 12 億美元。摩特世的股本回報率為 15.60%，淨利潤率為 11.91%。該公司的收入同比增長 91.4%。去年同期，該公司每股收益為 2.25 美元。摩特世已將其 2026 年第二季度的指導目標設定為 2.950-3.050 美元每股收益，並將其 2026 財年的指導目標設定為 14.400-14.600 美元每股收益。平均而言，股票分析師預計摩特世今年將發佈 14.5 美元的每股收益。</p>
<h2>內部買賣</h2>
<p>在相關消息中，董事魏江在 3 月 16 日的交易中購買了 500 股該股票。該股票的平均購買成本為每股 289.46 美元，總價值為 144,730.00 美元。交易後，該董事持有公司 3,441 股股票，價值 996,031.86 美元。這代表其持股增加了 17.00%。該購買在向證券交易委員會提交的文件中披露，文件可通過 SEC 網站訪問。內部人士持有公司 0.31% 的股票。</p>
<h2>機構投資者對摩特世的看法</h2>
<p>一些對沖基金最近對該公司的持倉進行了調整。先鋒集團在第三季度將其在摩特世股票中的持股增加了 3.3%。先鋒集團目前持有摩特世醫療儀器供應商的 7,656,891 股股票，價值 2,295,612,000 美元，在此期間又購買了 246,128 股。Fundsmith LLP 在第三季度將其在摩特世股票中的持股增加了 9.6%。Fundsmith LLP 目前持有摩特世醫療儀器供應商的 3,955,498 股股票，價值 1,185,898,000 美元，在此期間又購買了 347,091 股。Janus Henderson Group PLC 在第一季度將其在摩特世股票中的持股增加了 27.0%。Janus Henderson Group PLC 目前持有摩特世醫療儀器供應商的 1,638,772 股股票，價值 488,028,000 美元，在此期間又購買了 348,379 股。Geode Capital Management LLC 在第四季度將其在摩特世股票中的持股增加了 0.5%。Geode Capital Management LLC 目前持有摩特世醫療儀器供應商的 1,593,388 股股票，價值 602,921,000 美元，在此期間又購買了 8,590 股。最後，景順有限公司在第三季度將其在摩特世股票中的持股增加了 32.3%。景順有限公司目前持有摩特世醫療儀器供應商的 1,472,419 股股票，價值 441,446,000 美元，在上個季度又購買了 359,596 股。94.01% 的股票目前由機構投資者持有。</p>
<h2>摩特世公司簡介</h2>
<p>（獲取免費報告）</p>
<p>摩特世公司是一家全球性的分析儀器、軟件和服務提供商，專注於實驗室和研究應用。該公司設計、製造和銷售以液相色譜、質譜、分離科學及相關樣品準備和檢測系統為中心的技術。其產品組合包括色譜儀、質譜儀、色譜柱和耗材、實驗室信息學和工作流程軟件，以及幫助客户進行復雜分析的技術支持和培訓服務。</p>
<p>摩特世服務於廣泛的終端市場，包括製藥和生物技術公司、合同研究和測試實驗室、學術和政府研究機構、臨牀診斷、食品和環境檢測，以及工業和化學制造商。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票比沃特世更好</li>
<li>FirstCash 將典當業務轉變為增長機器</li>
<li>HubSpot 剛剛擊碎了空頭論——更大的反彈在前嗎？</li>
<li>激進的內部人士買入信號在三隻風險股票中顯示機會</li>
<li>光速：五隻推動人工智能光學未來的股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdBVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdBVA"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在沃特世嗎？</h2>
<p>在考慮沃特世之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而沃特世並不在名單上。</p>
<p>雖然沃特世目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

沃特世

<p>美國銀行將沃特世（NYSE:WAT）的目標股價從 370 美元上調至 400 美元，維持 “中性” 評級。這一調整是在其他分析師行動之後，包括摩根士丹利的下調和富國銀行的上調。該股票最近公佈了強勁的第一季度財報，EPS 和收入均超出預期，收入同比增長 91.4%。像先鋒集團和 Fundsmith 這樣的機構投資者在第三季度增加了他們的持股</p>

<p>Waters (NYSE:WAT - Get Free Report) had its target price lifted by analysts at Bank of America from $370.00 to $400.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has a &#34;neutral&#34; rating on the medical instruments supplier's stock. Bank of America's target price suggests a potential upside of 7.78% from the company's current price.</p>
<div class="lb-trans"><p>摩特世（NYSE:WAT - 獲取免費報告）在週二發佈的研究報告中，分析師將其目標價格從 370.00 美元上調至 400.00 美元，彭博社報道。該券商目前對這家醫療儀器供應商的股票給予 “中性” 評級。摩特世的目標價格暗示該公司當前價格有 7.78% 的潛在上漲空間。</p>
</div><ul>
<li>Agilent Technologies Thrives From the Forever Chemicals Crackdown</li>
</ul>
<div class="lb-trans"><ul>
<li>安捷倫科技因 “永恆化學品” 打擊而蓬勃發展</li>
</ul>
</div><p>WAT has been the subject of a number of other research reports. Morgan Stanley reduced their price objective on Waters from $423.00 to $350.00 and set an &#34;equal weight&#34; rating for the company in a research report on Sunday, February 22nd. Weiss Ratings reaffirmed a &#34;hold (c)&#34; rating on shares of Waters in a research note on Monday, April 20th. Wells Fargo &amp; Company lifted their target price on Waters from $355.00 to $370.00 and gave the company an &#34;equal weight&#34; rating in a research note on Thursday, May 14th. TD Cowen boosted their price objective on Waters from $345.00 to $385.00 and gave the stock a &#34;hold&#34; rating in a research note on Wednesday, May 6th. Finally, Guggenheim reissued a &#34;buy&#34; rating and issued a $440.00 price objective on shares of Waters in a research note on Tuesday, February 10th. Three analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and eight have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Waters presently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $395.71.</p>
<div class="lb-trans"><p>WAT 還受到其他多份研究報告的關注。摩根士丹利在 2 月 22 日的研究報告中將摩特世的目標價格從 423.00 美元下調至 350.00 美元，並給予該公司 “等權重” 評級。Weiss Ratings 在 4 月 20 日的研究報告中重申了對摩特世股票的 “持有（c）” 評級。富國銀行在 5 月 14 日的研究報告中將摩特世的目標價格從 355.00 美元上調至 370.00 美元，並給予該公司 “等權重” 評級。TD Cowen 在 5 月 6 日的研究報告中將摩特世的目標價格從 345.00 美元上調至 385.00 美元，並給予該股票 “持有” 評級。最後，古根海姆在 2 月 10 日的研究報告中重新發布了 “買入” 評級，並對摩特世股票設定了 440.00 美元的目標價格。三位分析師給予該股票 “強烈買入” 評級，九位給予 “買入” 評級，八位給予 “持有” 評級。根據 MarketBeat.com 的數據，摩特世目前的共識評級為 “適度買入”，平均目標價格為 395.71 美元。</p>
</div><p><strong>View Our Latest Stock Analysis on Waters</strong></p>
<div class="lb-trans"><p><strong>查看我們對摩特世的最新股票分析</strong></p>
</div><h2>Waters Stock Performance</h2>
<div class="lb-trans"><h2>摩特世股票表現</h2>
</div><ul>
<li>Medical Stocks Waters, Agilent, Illumina Show Growth Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>醫療股票摩特世、安捷倫、Illumina 顯示增長潛力</li>
</ul>
</div><p>Shares of WAT traded down $5.86 during mid-day trading on Tuesday, hitting $371.11. The stock had a trading volume of 1,529,432 shares, compared to its average volume of 1,186,656. The company has a market cap of $36.44 billion, a PE ratio of 47.49, a PEG ratio of 2.42 and a beta of 1.21. The company's fifty day simple moving average is $325.28 and its two-hundred day simple moving average is $350.93. The company has a quick ratio of 1.13, a current ratio of 1.79 and a debt-to-equity ratio of 0.32. Waters has a fifty-two week low of $275.05 and a fifty-two week high of $414.15.</p>
<div class="lb-trans"><p>週二中午交易時，WAT 的股價下跌 5.86 美元，跌至 371.11 美元。該股票的交易量為 1,529,432 股，而其平均交易量為 1,186,656 股。該公司的市值為 364.4 億美元，市盈率為 47.49，市盈增長比率為 2.42，貝塔值為 1.21。該公司的 50 日簡單移動平均線為 325.28 美元，200 日簡單移動平均線為 350.93 美元。該公司的速動比率為 1.13，流動比率為 1.79，債務與股本比率為 0.32。摩特世的 52 周低點為 275.05 美元，52 周高點為 414.15 美元。</p>
</div><p>Waters (NYSE:WAT - Get Free Report) last issued its earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 EPS for the quarter, topping the consensus estimate of $2.31 by $0.39. The company had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.20 billion. Waters had a return on equity of 15.60% and a net margin of 11.91%.The business's revenue was up 91.4% on a year-over-year basis. During the same quarter last year, the firm earned $2.25 EPS. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. On average, equities analysts expect that Waters will post 14.5 earnings per share for the current year.</p>
<div class="lb-trans"><p>摩特世（NYSE:WAT - 獲取免費報告）在 5 月 5 日最後發佈了其財報。這家醫療儀器供應商報告本季度每股收益為 2.70 美元，超出市場共識預期的 2.31 美元，超出幅度為 0.39 美元。該公司本季度的收入為 12.7 億美元，而分析師預期為 12 億美元。摩特世的股本回報率為 15.60%，淨利潤率為 11.91%。該公司的收入同比增長 91.4%。去年同期，該公司每股收益為 2.25 美元。摩特世已將其 2026 年第二季度的指導目標設定為 2.950-3.050 美元每股收益，並將其 2026 財年的指導目標設定為 14.400-14.600 美元每股收益。平均而言，股票分析師預計摩特世今年將發佈 14.5 美元的每股收益。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>內部買賣</h2>
</div><p>In related news, Director Wei Jiang purchased 500 shares of the stock in a transaction that occurred on Monday, March 16th. The stock was acquired at an average cost of $289.46 per share, with a total value of $144,730.00. Following the transaction, the director owned 3,441 shares of the company's stock, valued at $996,031.86. This represents a 17.00% increase in their position. The purchase was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through the SEC website. Insiders own 0.31% of the company's stock.</p>
<div class="lb-trans"><p>在相關消息中，董事魏江在 3 月 16 日的交易中購買了 500 股該股票。該股票的平均購買成本為每股 289.46 美元，總價值為 144,730.00 美元。交易後，該董事持有公司 3,441 股股票，價值 996,031.86 美元。這代表其持股增加了 17.00%。該購買在向證券交易委員會提交的文件中披露，文件可通過 SEC 網站訪問。內部人士持有公司 0.31% 的股票。</p>
</div><h2>Institutional Investors Weigh In On Waters</h2>
<div class="lb-trans"><h2>機構投資者對摩特世的看法</h2>
</div><p>A number of hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. grew its stake in shares of Waters by 3.3% during the 3rd quarter. Vanguard Group Inc. now owns 7,656,891 shares of the medical instruments supplier's stock worth $2,295,612,000 after acquiring an additional 246,128 shares during the period. Fundsmith LLP raised its stake in shares of Waters by 9.6% during the 3rd quarter. Fundsmith LLP now owns 3,955,498 shares of the medical instruments supplier's stock valued at $1,185,898,000 after purchasing an additional 347,091 shares during the period. Janus Henderson Group PLC raised its stake in shares of Waters by 27.0% during the 1st quarter. Janus Henderson Group PLC now owns 1,638,772 shares of the medical instruments supplier's stock valued at $488,028,000 after purchasing an additional 348,379 shares during the period. Geode Capital Management LLC raised its stake in shares of Waters by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 1,593,388 shares of the medical instruments supplier's stock valued at $602,921,000 after purchasing an additional 8,590 shares during the period. Finally, Invesco Ltd. raised its holdings in shares of Waters by 32.3% in the 3rd quarter. Invesco Ltd. now owns 1,472,419 shares of the medical instruments supplier's stock valued at $441,446,000 after acquiring an additional 359,596 shares in the last quarter. 94.01% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>一些對沖基金最近對該公司的持倉進行了調整。先鋒集團在第三季度將其在摩特世股票中的持股增加了 3.3%。先鋒集團目前持有摩特世醫療儀器供應商的 7,656,891 股股票，價值 2,295,612,000 美元，在此期間又購買了 246,128 股。Fundsmith LLP 在第三季度將其在摩特世股票中的持股增加了 9.6%。Fundsmith LLP 目前持有摩特世醫療儀器供應商的 3,955,498 股股票，價值 1,185,898,000 美元，在此期間又購買了 347,091 股。Janus Henderson Group PLC 在第一季度將其在摩特世股票中的持股增加了 27.0%。Janus Henderson Group PLC 目前持有摩特世醫療儀器供應商的 1,638,772 股股票，價值 488,028,000 美元，在此期間又購買了 348,379 股。Geode Capital Management LLC 在第四季度將其在摩特世股票中的持股增加了 0.5%。Geode Capital Management LLC 目前持有摩特世醫療儀器供應商的 1,593,388 股股票，價值 602,921,000 美元，在此期間又購買了 8,590 股。最後，景順有限公司在第三季度將其在摩特世股票中的持股增加了 32.3%。景順有限公司目前持有摩特世醫療儀器供應商的 1,472,419 股股票，價值 441,446,000 美元，在上個季度又購買了 359,596 股。94.01% 的股票目前由機構投資者持有。</p>
</div><h2>Waters Company Profile</h2>
<div class="lb-trans"><h2>摩特世公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.</p>
<div class="lb-trans"><p>摩特世公司是一家全球性的分析儀器、軟件和服務提供商，專注於實驗室和研究應用。該公司設計、製造和銷售以液相色譜、質譜、分離科學及相關樣品準備和檢測系統為中心的技術。其產品組合包括色譜儀、質譜儀、色譜柱和耗材、實驗室信息學和工作流程軟件，以及幫助客户進行復雜分析的技術支持和培訓服務。</p>
</div><p>Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.</p>
<div class="lb-trans"><p>摩特世服務於廣泛的終端市場，包括製藥和生物技術公司、合同研究和測試實驗室、學術和政府研究機構、臨牀診斷、食品和環境檢測，以及工業和化學制造商。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Waters</li>
<li>FirstCash Turns Pawn Into a Growth Machine</li>
<li>HubSpot Just Crushed the Bear Case—Is a Bigger Rally Ahead?</li>
<li>Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks</li>
<li>The Speed of Light: 5 Stocks Powering AI’s Optical Future</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比沃特世更好</li>
<li>FirstCash 將典當業務轉變為增長機器</li>
<li>HubSpot 剛剛擊碎了空頭論——更大的反彈在前嗎？</li>
<li>激進的內部人士買入信號在三隻風險股票中顯示機會</li>
<li>光速：五隻推動人工智能光學未來的股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdBVA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=WAT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Waters Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在沃特世嗎？</h2>
</div><p>Before you consider Waters, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮沃特世之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而沃特世並不在名單上。</p>
</div><p>While Waters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然沃特世目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Waters (NYSE:WAT) Price Target Raised to $400.00

Market Beat

美國銀行

安捷倫科技

摩根士丹利

富國銀行

Illumina

Janus Henderson

景順投資管理

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

沃特世（NYSE:WAT）的目標股價被上調至 400.00 美元